3,574
Views
28
CrossRef citations to date
0
Altmetric
Research Paper

Whole genome bisulfite sequencing of Down syndrome brain reveals regional DNA hypermethylation and novel disorder insights

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 672-684 | Received 23 Jan 2019, Accepted 15 Apr 2019, Published online: 06 May 2019

References

  • Parker SE, Mai CT, Canfield MA, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res Part A Clin Mol Teratol. 2010;88:1008–1016.
  • Mai CT, Kucik JE, Isenburg J, et al. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res Part A Clin Mol Teratol. 2013;97:709–725.
  • Shin M, Besser LM, Kucik JE, et al. Congenital anomaly multistate prevalence and survival collaborative prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics. 2009;124:1565–1571.
  • Presson AP, Partyka G, Jensen KM, et al. Current estimate of Down syndrome population prevalence in the United States. J Pediatr. 2013;163:1163–1168.
  • Korenberg JR, Chen XN, Schipper R, et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U S A. 1994;91:4997–5001.
  • Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down’s syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 2002;359:1019–1025.
  • Antonarakis SE. Down syndrome and the complexity of genome dosage imbalance. Nat Rev Genet. 2016;18:147–163.
  • Do C, Xing Z, Yu YE, et al. Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models. Epigenomics. 2017;9:189–207.
  • Mao R, Zielke CL, Zielke HR, et al. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics. 2003;81:457–467.
  • Antonarakis SE, Lyle R, Dermitzakis ET, et al. 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet. 2004;5:725–738.
  • Olmos-Serrano JL, Kang HJ, Tyler WA, et al. Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron. 2016;89:1208–1222.
  • Letourneau A, Santoni FA, Bonilla X, et al. Domains of genome-wide gene expression dysregulation in Down’s syndrome. Nature. 2014;508:345–350.
  • Sailani MR, Santoni FA, Letourneau A, et al. DNA-methylation patterns in trisomy 21 using cells from monozygotic twins. PLoS One. 2015;10:e0135555.
  • Kerkel K, Schupf N, Hatta K, et al. Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet. 2010;6:e1001212.
  • Bacalini MG, Gentilini D, Boattini A, et al. Identification of a DNA methylation signature in blood cells from persons with Down syndrome. Aging (Albany NY). 2014;7:82–96.
  • Malinge S, Chlon T, Dore LC, et al. Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. Blood. 2013;122:e33–43.
  • Jones MJ, Farré P, McEwen LM, et al. Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in Down syndrome. BMC Med Genomics. 2013;6:58.
  • Smith AK, Kilaru V, Klengel T, et al. DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain. Am J Med Genet Part B Neuropsychiatr Genet. 2015;168:36–44.
  • Jin S, Lee YK, Lim YC, et al. Global DNA hypermethylation in down syndrome placenta. PLoS Genet. 2013;9:e1003515.
  • Mendioroz M, Do C, Jiang X, et al. Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models. Genome Biol. 2015;16:263.
  • El Hajj N, Dittrich M, Böck J, et al. Epigenetic dysregulation in the developing Down syndrome cortex. Epigenetics. 2016;11:563–578.
  • Lu J, Mccarter M, Lian G, et al. Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression. Hum Mol Genet. 2016;25:1714–1727.
  • Dunaway KW, Islam MS, Coulson RL, et al. Cumulative impact of polychlorinated biphenyl and large chromosomal duplications on DNA methylation, chromatin, and expression of autism candidate genes. Cell Rep. 2016;17:3035–3048.
  • Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat Methods. 2012;9:215–216.
  • Consortium RE, Kundaje A, Meuleman W, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518:317–330.
  • Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507:455–461.
  • Brosnan ME, Brosnan JT. Formate: the neglected member of one-carbon metabolism. Annu Rev Nutr. 2016;36:369–388.
  • Antonelli R, De Filippo R, Middei S, et al. Pin1 modulates the synaptic content of NMDA receptors via prolyl-isomerization of PSD-95. J Neurosci. 2016;36:5437–5447.
  • Howe FS, Boubriak I, Sale MJ, et al. Lysine acetylation controls local protein conformation by influencing proline isomerization. Mol Cell. 2014;55:733–744.
  • Nelson CJ, Santos-Rosa H, Kouzarides T. Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell. 2006;126:905–916.
  • Laurendeau I, Ferrer M, Garrido D, et al. Gene expression profiling of the hedgehog signaling pathway in human meningiomas. Mol Med. 2010;16:262–270.
  • Inoue K, Shiga T, Ito Y. Runx transcription factors in neuronal development. Neural Dev. 2008;3:20.
  • Wayman GA, Yang D, Bose DD, et al. PCB-95 promotes dendritic growth via ryanodine receptor-dependent mechanisms. Environ Health Perspect. 2012;120:997–1002.
  • Söllner C, Wright GJ. A cell surface interaction network of neural leucine-rich repeat receptors. Genome Biol. 2009;10:R99.
  • Gilsohn E, Volk T. Fine tuning cellular recognition: the function of the leucine rich repeat (LRR) trans-membrane protein, LRT, in muscle targeting to tendon cells. Cell Adh Migr. 2010;4:368–371.
  • Tissir F, Bar I, Jossin Y, et al. Protocadherin Celsr3 is crucial in axonal tract development. Nat Neurosci. 2005;8:451–457.
  • Bonnefont J, Nikolaev SI, Perrier AL, et al. Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. Am J Hum Genet. 2008;83:208–218.
  • W V C, Maniatis T. Clustered protocadherins. Development. 2013;140:3297–3302.
  • Hayashi S, Takeichi M. Emerging roles of protocadherins: from self-avoidance to enhancement of motility. J Cell Sci. 2015;128:1455–1464.
  • Powers RK, Sullivan KD, Culp-Hill R, et al. Trisomy 21 drives production of neurotoxic tryptophan catabolites via the interferon-inducible kynurenine pathway. bioRxiv. 2018:403642.
  • Aziz NM, Guedj F, Pennings JLA, et al. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome. Dis Model Mech. 2018;11:dmm031013.
  • Sullivan KD, Lewis HC, Hill AA, et al. Trisomy 21 consistently activates the interferon response. Elife. 2016:5.
  • Filiano AJ, Xu Y, Tustison NJ, et al. Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. Nature. 2016;535:425–429.
  • Kim IS, Lee M, Park KC, et al. Roles of Mis18α in epigenetic regulation of centromeric chromatin and CENP-A loading. Mol Cell. 2012;46:260–273.
  • Chedin F, Lieber MR, Hsieh C-L. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc Natl Acad Sci. 2002;99:16916–16921.
  • Chen Z-X, Mann JR, Hsieh C-L, et al. Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem. 2005;95:902–917.
  • Jeltsch A, Jurkowska RZ. Allosteric control of mammalian DNA methyltransferases – a new regulatory paradigm. Nucleic Acids Res. 2016;44:8556–8575.
  • Ooi SKT, Qiu C, Bernstein E, et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature. 2007;448:714–717.
  • Otani J, Nankumo T, Arita K, et al. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 2009;10:1235–1241.
  • Ratnu VS, Emami MR, Bredy TW. Genetic and epigenetic factors underlying sex differences in the regulation of gene expression in the brain. J Neurosci Res. 2017;95:301–310.
  • Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27:1571–1572.
  • Wingett SW, FastQ Screen: AS. A tool for multi-genome mapping and quality control. F1000Res. 2018;7:1338.
  • Ewels P, Magnusson M, Lundin S, et al. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32:3047–3048.
  • Korthauer K, Chakraborty S, Benjamini Y, et al. Detection and accurate false discovery rate control of differentially methylated regions from whole genome bisulfite sequencing. Biostatistics. 2018.
  • Hansen KD, Langmead B, Irizarry RA. BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions. Genome Biol. 2012;13:R83.
  • Cavalcante RG, Sartor MA. annotatr: genomic regions in context. Bioinformatics. 2017;33:2381–2383.
  • Yu G, Wang L-G, He Q-Y. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382–2383.
  • McLean CY, Bristor D, Hiller M, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495–501.
  • Supek F, Bošnjak M, Škunca N, et al. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One. 2011;6:e21800.
  • Heger A, Webber C, Goodson M, et al. GAT: a simulation framework for testing the association of genomic intervals. Bioinformatics. 2013;29:2046–2048.
  • Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576–589.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.